Switching Between Biological Treatments in Psoriatic Arthritis: A Review of the Evidence

Psoriatic arthritis (PsA) is a chronic inflammatory arthropathy. Therapy with anti-tumor necrosis factor (TNF)-α agents represents the first therapeutic choice for moderate and severe forms; however, PsA patients can experience anti-TNFα failure, lack of efficacy, or adverse events. Several evidence...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Drugs R D
Autors principals: Costa, Luisa, Perricone, Carlo, Chimenti, Maria Sole, Del Puente, Antonio, Caso, Paolo, Peluso, Rosario, Bottiglieri, Paolo, Scarpa, Raffaele, Caso, Francesco
Format: Artigo
Idioma:Inglês
Publicat: Springer International Publishing 2017
Matèries:
Review Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5694428/
https://ncbi.nlm.nih.gov/pubmed/29058302
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40268-017-0215-7
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars